Private Equity
Andrea Alms Video: Money In Motion 114 - Leukemia Therapeutics Market Overview
July 2024 - Private Equity
TRANSCRIPT Hello, my name is Andrea Alms. I'm a technology investor and financial manager and this is your Money in Motion. What is it? Leukemia is a type of cancer that affects the blood and bone marrow, usually white blood cells. The outcome of leukemia depends on several factors, including the type of leukemia. The patient's age. General condition. Patients with leukemia may die from multiple infection, nutritional deficiencies, or organ system failure.
In acute leukemia, 70% of patients die from infection, 52 from hemorrhage. 1.6 million Americans are affected by blood cancer, with a 66.7% survival rate. Every three minutes, an American receives a blood cancer diagnosis at markets such as the global leukemia therapeutic market. Size was 16.2 billion U.S. dollars in 2022, with a compound average growth rate of 7.8%. At research and markets, the market size was 16.25 billion in 2023 and expected to grow to 21.57 billion by 2027, at a compound average growth rate of 7.3%.
At MMR, the market was 14.19 billion in 2022 and expected to reach 24.07 billion by 2029, at a growth rate of 7.84%. Averaging the averages, the market was 15.5 billion at a 7.6% growth rate. Thank you. This was your money. Your money in motion.